EMAIL THIS PAGE TO A FRIEND

Tissue Engineering: Part C, Methods

Effects of Stirring and Fluid Perfusion on the In Vitro Degradation of Calcium Phosphate Cement/PLGA Composites.


PMID 26094637

Abstract

We're sorry this abstract is currently not available.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

16483
β-tri-Calcium phosphate, puriss. p.a., ≥95% β-phase basis (sintered powder)
Ca3O8P2
C3161
Calcium phosphate tribasic, BioReagent, plant cell culture tested, powder
HCa5O13P3
C5267
Calcium phosphate tribasic, 34.0-40.0% Ca basis
HCa5O13P3
L1250
DL-Lactic acid, 85 % (w/w), syrup
C3H6O3
124737
Glycolic acid, ReagentPlus®, 99%
C2H4O3
G8284
Glycolic acid, BioXtra, ≥98.0% (titration)
C2H4O3
420581
Glycolic acid solution, high purity, 70 wt. % in H2O
C2H4O3
420603
Glycolic acid solution, technical grade, 70 wt. % in H2O
C2H4O3
702153
Hydroxyapatite, nanoparticles, dispersion, 10 wt. % in H2O, <200 nm particle size (BET)
Ca5HO13P3
H0252
Hydroxyapatite, Type I, buffered aqueous suspension
HCa5O13P3
55497
Hydroxyapatite, ′fast flow′
HCa5O13P3
04238
Hydroxyapatite, puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
HCa5O13P3
574791
Hydroxyapatite, synthetic, 99.8% trace metals basis (excludes Mg)
HCa5O13P3
21223
Hydroxyapatite, purum p.a., ≥90% (as Ca3(PO4)2, KT)
HCa5O13P3
289396
Hydroxyapatite, reagent grade, powder, synthetic
HCa5O13P3
677418
Hydroxyapatite, nanopowder, <200 nm particle size (BET), ≥97%, synthetic
HCa5O13P3
693863
Hydroxyapatite, nanopowder, <200 nm particle size (BET), contains 5 wt. % silica as dopant, synthetic
HCa5O13P3
W261106
Lactic acid, 85%, FCC
C3H6O3
L6661
Lactic acid, meets USP testing specifications
C3H6O3
W261114
Lactic acid, natural, ≥85%
C3H6O3
252476
Lactic acid solution, ACS reagent, ≥85%
C3H6O3